<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Paul Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Rev Paul Pediatr</journal-id><journal-id journal-id-type="publisher-id">rpp</journal-id><journal-title-group><journal-title>Revista Paulista de Pediatria</journal-title></journal-title-group><issn pub-type="ppub">0103-0582</issn><issn pub-type="epub">1984-0462</issn><publisher><publisher-name>Sociedade de Pediatria de S&#x000e3;o Paulo</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26684442</article-id><article-id pub-id-type="pmc">4795718</article-id><article-id pub-id-type="doi">10.1016/j.rppede.2015.06.021</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Influence of polymorphisms of the beta-2 adrenergic receptor on the
presence of exercise-induced bronchospasm in adolescents<xref ref-type="author-notes" rid="fn1">&#x02730;</xref>
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Consentino</surname><given-names>C&#x000e1;ssio Leandro M&#x000fc;he</given-names></name><xref ref-type="aff" rid="aff1">a</xref><xref ref-type="corresp" rid="c1">*</xref></contrib><contrib contrib-type="author"><name><surname>Furtado-Alle</surname><given-names>Lupe</given-names></name><xref ref-type="aff" rid="aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>da Silva</surname><given-names>Larissa Rosa</given-names></name><xref ref-type="aff" rid="aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Wendell Arthur</given-names></name><xref ref-type="aff" rid="aff2">b</xref></contrib><contrib contrib-type="author"><name><surname>Tureck</surname><given-names>Luciane Viater</given-names></name><xref ref-type="aff" rid="aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>Milano</surname><given-names>Gerusa Einsfeld</given-names></name><xref ref-type="aff" rid="aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>Lazarotto</surname><given-names>Leilane</given-names></name><xref ref-type="aff" rid="aff1">a</xref></contrib><contrib contrib-type="author"><name><surname>Cavaglieri</surname><given-names>Cl&#x000e1;udia Regina</given-names></name><xref ref-type="aff" rid="aff3">c</xref></contrib><contrib contrib-type="author"><name><surname>Leite</surname><given-names>Neiva</given-names></name><xref ref-type="aff" rid="aff1">a</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Universidade Federal do Paran&#x000e1; (UFPR), Curitiba, PR, Brazil</aff><aff id="aff2"><label>b</label>Universidade Estadual de Maring&#x000e1; (UEM), Ivaipor&#x000e3;, PR, Brazil</aff><aff id="aff3"><label>c</label>Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil</aff><author-notes><corresp id="c1"><label>*</label> Corresponding author. <italic>E-mail:</italic><email>cassioleandromc@hotmail.com</email> (C.L.M. Consentino).</corresp><fn fn-type="conflict"><p>
<bold>Conflicts of interest</bold>
</p><p>The authors declare no conflicts of interest. LFA is a researcher at Araucaria
Foundation, LRS is Capes doctoral fellow, WAL is CNPq doctoral fellow, CRC and NL
have CNPq productivity grants.</p></fn><fn fn-type="other" id="fn1"><label>&#x02730; </label><p>This article is part of the Master&#x02019;s Degree Dissertation of C&#x000e1;ssio Leandro M&#x000fc;he
Consentino.</p></fn></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Mar</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2016</year></pub-date><volume>34</volume><issue>1</issue><fpage>24</fpage><lpage>29</lpage><history><date date-type="received"><day>2</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>9</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Sociedade de Pediatria de S&#x000e3;o Paulo. Published by Elsevier
Editora Ltda</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective:</title><p>To determine the influence of polymorphisms of the beta-2 adrenergic receptor
(ADRB2) in triggering exercise-induced bronchospasm (EIB) in adolescents.</p></sec><sec><title>Methods:</title><p>The subjects were divided into two groups: present EIB (EIB+) (n=45) and absent
EIB (EIB&#x02212;) (n=115). The bronchial provocation test with exercise was performed
with a protocol that consisted of walking/running for at least eight minutes at
high intensity, i.e., &#x0003e;85% of maximum heart rate, considering EIB+ as a 10%
decrease in forced expiratory volume in one second (FEV<sub>1</sub>). The
genotyping of the <italic>ADRB2</italic> gene was performed by the Taqman method,
using the Step One Plus system. Independent <italic>t</italic>-test, Mann&#x02013;Whitney
and Chi-square tests, as well as Spearman's correlation coefficient were used for
the statistical analysis.</p></sec><sec><title>Results:</title><p>Age, body weight, height, FEV<sub>1</sub>, FVC and FEV<sub>1</sub>/FVC ratio were
lower in the EIB+ group when compared to EIB&#x02212; (<italic>p</italic>&#x0003c;0.05). There
were no significant differences in the proportion of the allele at position 27 and
<italic>Arg16Gly</italic> and <italic>Gln27Glu</italic> genotypes between the
EIB+ and EIB&#x02212; groups (<italic>p</italic>=0.26; <italic>p</italic>=0.97 and
<italic>p</italic>=0.43, respectively). However, there was a trend toward
statistical significance regarding the greater proportion of the Gly16 allele for
the EIB+ when compared to the EIB&#x02212; group (<italic>p</italic>=0.08).</p></sec><sec><title>Conclusions:</title><p>The presence of polymorphisms associated with the Glu27 allele and
<italic>Arg16Gly</italic> and <italic>Gln27Glu</italic> genotypes had no
influence on EIB. However, the statistical trend toward greater frequency of the
<italic>Gly16</italic> allele in individuals with EIB+ can be considered
evidence of the influence of polymorphisms of the <italic>ADBR2</italic> gene on
EIB in adolescents.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd>Adolescent</kwd><kwd>Exercise-induced bronchospasm</kwd><kwd>ADRB2 gene</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Exercise-induced bronchospasm (EIB) is defined as temporary narrowing of the airways
that occurs after strenuous exercise in up to 90% of asthmatic individuals<xref rid="B1" ref-type="bibr">1</xref> and in almost 20% of individuals with no history of
respiratory disease.<xref rid="B2" ref-type="bibr">2</xref> The presence of excess
weight can contribute to increased severity of EIB in asthmatics.<xref rid="B3" ref-type="bibr">3</xref> The excessive accumulation of fatty tissue in the central region
can change the pulmonary mechanics and airway inflammatory response, leading to
increased contractility and responsiveness of bronchial smooth muscle<xref rid="B4" ref-type="bibr">4</xref> and thus limit the practice of physical
exercises<xref rid="B5" ref-type="bibr">5</xref> as therapy for asthma<xref rid="B6" ref-type="bibr">6</xref> and obesity.<xref rid="B7" ref-type="bibr">7</xref>
</p><p>Some genetic alterations, such as polymorphisms of the beta adrenergic receptor 2
(<italic>ADRB2</italic>), have been associated with the presence of asthma<xref rid="B8" ref-type="bibr">8</xref> and obesity.<xref rid="B9" ref-type="bibr">9</xref>
The <italic>ADRB2</italic> gene is located on chromosome 5q31 and can be found in
several regions of the body, including smooth muscle.<xref rid="B10" ref-type="bibr">10</xref>
<italic>ADRB2</italic> act through mediation by adrenaline and noradrenaline action and
promote smooth muscle relaxation, even in the pulmonary region,<xref rid="B11" ref-type="bibr">11</xref> as well as playing an important role in bronchodilation during
exercise in healthy individuals.<xref rid="B12" ref-type="bibr">12</xref> The
<italic>Arg16Gly</italic> and <italic>Gln27Glu</italic> polymorphisms of the
<italic>ADRB2</italic> gene have been associated with asthma symptoms,<xref rid="B7" ref-type="bibr">7</xref> including reduction in the pulmonary function and
in the bronchodilation response to medication, as they have negative influence on the
bronchodilator effect,<xref rid="B13" ref-type="bibr">13</xref> a therapeutic resource
that is part of pre-exercise EIB prevention.<xref rid="B14" ref-type="bibr">14</xref>
</p><p>Recently, our research group found a higher presence of <italic>Arg16Gly</italic>
polymorphism in children and adolescents with asthma when compared with controls.
Additionally, there was a trend for a higher frequency of polymorphism
<italic>Gly16</italic> in asthmatics with excess weight.<xref rid="B15" ref-type="bibr">15</xref> However, the influence of the polymorphism presence on the
<italic>ADRB2</italic> receptor in the presence of EIB in children and adolescents
has not been investigated. Our hypothesis is that the higher frequency of polymorphisms
in <italic>ADRB2</italic> receptor could be related to higher presence of EIB in this
population. Therefore, the aim of this study was to determine the influence of
polymorphisms in the <italic>ADRB2</italic> gene on the triggering of EIB in
adolescents.</p></sec><sec sec-type="methods"><title>Method</title><p>This was a cross-sectional study of 160 adolescents of both genders, of Caucasian
ethnicity, aged between 9 and 17 years, selected for convenience and from public schools
in the city of Curitiba, state of Parana, Brazil. The sample was divided in two groups,
with EIB (EIB+) (n=45) and without EIB (EIB&#x02212;) (n=115). The presence of EIB was verified
when there was a decrease &#x02265;10% in FEV<sub>1</sub> in relation to the baseline value at
the bronchial provocation test through exercise. All participants and parents/tutors
signed the free and informed consent form, according to the research project approved by
the Ethics Committee on Human Research of Hospital de Clinicas of Universidade Federal
do Parana (protocol n. 2460.067/2011-03). Sample size calculation was performed with a
95% confidence level and the formula described by Santos.<xref rid="B16" ref-type="bibr">16</xref> The size of the calculated sample was of 246 students. However, the number
of participants comprised 160 adolescents, 65% of the expected sample, due to the
complexity of the tests and the need for blood collection.</p><p>Body weight (kg) was measured on a digital scale (Toledo<sup>&#x000ae;</sup>) with 0.1kg
resolution, and height (cm) in a stadiometer (Sanny<sup>&#x000ae;</sup>) with a resolution of
0.1cm. The body mass index (BMI) was calculated using the formula: BMI
(kg/m<sup>2</sup>)=body mass (kg)/height<sup>2</sup> (m). This variable was converted to
BMI <italic>z</italic>-score, using the WHO Anthroplus software v.1.0.4 developed by the
World Health Organization (WHO), classified according to the cutoff points proposed by
the WHO in 2006.<xref rid="B17" ref-type="bibr">17</xref>
</p><p>Waist circumference (WC) was measured in centimeters (cm) using an inextensible
anthropometric tape (Cardiomed<sup>&#x000ae;</sup>), measured at midpoint between the last rib
and the iliac crest, with the individual in the standing position, relaxed abdomen and
arms positioned along the body. The classification used the values proposed by Fern&#x000e1;ndez
et al. in 2004.<xref rid="B18" ref-type="bibr">18</xref>
</p><p>The diagnosis of asthma, according to the III Brazilian Consensus on Asthma Management
(SBPT, 2002)<xref rid="B19" ref-type="bibr">19</xref> was performed using medical
assessment and the International Study of Asthma and Allergies in Childhood (ISAAC)
questionnaire and the disease was confirmed through the answer to question number 6.</p><p>Pulmonary function was assessed by spirometry in the pre-exercise and post-exercise (5,
10 and 15min). They were made three maneuvers with the evaluated in a sitting position
and nose clip. The curves were selected that showed the highest values for the variables
of forced expiratory volume in one second (FEV<sub>1</sub>) and forced vital capacity
(FVC) in liters (L). The predicted values and the forced expiratory coefficient
(FEV<sub>1</sub>/FVC) were shown by the spirometer software (One brand
Flow<sup>&#x000ae;</sup>), using as reference values those proposed by Knudson et al.<xref rid="B20" ref-type="bibr">20</xref>
</p><p>The bronchial provocation test with exercise was carried out in a controlled environment
(temperature between 20 and 25&#x000b0;C and relative humidity of 50%), in the afternoon, on a
treadmill (Master Super ATL-Inbramed) with a protocol that consisted in walking/running
for eight minutes at an intensity &#x0003e;85% of maximum heart rate (HR<sub>max</sub>),
according to the American Thoracic Society guidelines.<xref rid="B14" ref-type="bibr">14</xref> HR<sub>max</sub> was calculated using the formula proposed by Tanaka et
al.<xref rid="B21" ref-type="bibr">21</xref> and monitored during the test using a
heart rate meter (Polar<sup>&#x000ae;</sup>). The assessed subjects were instructed not to drink
caffeine-based drinks two hours before the evaluation, discontinue use of short and
long-action bronchodilators 48h and 5 days before the evaluations, respectively.</p><p>The exercise was not performed when there were reports of asthma crisis or viral
infection of the airways in the 4 weeks before the test. The magnitude of the decrease
was calculated from the maximum decrease in FEV<sub>1</sub> (MDVEF<sub>1</sub>) through
the equation: MDFEV<sub>1</sub>=[(pre-exercise FEV<sub>1</sub>&#x02212;lowest post-exercise
FEV<sub>1</sub>)/pre-exercise FEV<sub>1</sub>]&#x000d7;100.<xref rid="B14" ref-type="bibr">14</xref> DNA was extracted from blood samples and genotyping polymorphisms
<italic>Arg16Gly</italic> and <italic>Gln27Glu</italic> of <italic>ADRB2</italic>
gene by performed through the Taqman method, using a TaqMan SNP genotyping assay kit of
Applied Biosystems and Eppendorf realplex v.1.5 software, with the Step One Plus
equipment. Next, a scatter plot (XY) was made for the FAM-VIC separation and subsequent
genotyping of each adolescent for each polymorphism. The individuals homozygous for the
amino acid arginine at codon 16 (<italic>ArgArg</italic>) and glutamine at codon 27
(<italic>GlnGln</italic>) were classified as normal, whereas individuals homozygous
at position 16 for the amino acid glycine (<italic>Gly</italic>) and at position 27, for
glutamic acid (<italic>GluGlu</italic>) were classified as carriers, as well as the
heterozygous individuals.</p><p>Statistical analysis was performed using SPSS software, version 19. Normality was
verified using the Kolmogorov&#x02013;Smirnov test, Student's <italic>t</italic> test was
applied in parametric variables to compare the groups, whereas the Mann&#x02013;Whitney
<italic>U</italic> test was applied on non-parametric ones. The chi-square test was
used to analyze the proportions between the groups. The correlation between variables
was assessed using Spearman's correlation coefficient and classified according to Dancey
and Reidy.<xref rid="B22" ref-type="bibr">22</xref> The significance level was set at
<italic>p</italic>&#x0003c;0.05.</p></sec><sec sec-type="results"><title>Results</title><p>The baseline characteristics of the groups are shown in <xref ref-type="table" rid="t1">Table 1</xref>. Differences were observed for the variables age, body weight,
height, FEV<sub>1</sub> (both in liters and percentage of predicted value) and FVC in
liters and in the FEV<sub>1</sub>/FVC ratio, being lower in the EIB+ group.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Anthropometric and baseline spirometric characteristics of the groups present
(+) and absent (&#x02212;) exercise-induced bronchospasm.</title></caption><table frame="hsides" rules="groups" style="border-color:#376bad"><colgroup span="1"><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/></colgroup><thead style="background-color:#bad2ed;border-color:#376bad"><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">EIB+ <break/> (n=45)</th><th align="left" rowspan="1" colspan="1">EIB&#x02212; <break/> (n=115)</th><th align="left" rowspan="1" colspan="1">
<italic>t</italic> or <italic>U</italic>
</th><th align="left" rowspan="1" colspan="1">
<italic>p</italic> -value</th></tr></thead><tbody style="background-color:#e5edf8;border-color:#376bad"><tr><td align="left" rowspan="1" colspan="1">Age (years) <xref ref-type="table-fn" rid="TFN3">a</xref>
</td><td align="char" rowspan="1" colspan="1">13.6&#x000b1;1.6</td><td align="char" rowspan="1" colspan="1">14.5&#x000b1;1.5 <xref ref-type="table-fn" rid="TFN2">**</xref>
</td><td align="char" rowspan="1" colspan="1">4.05</td><td align="char" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass (kg)</td><td align="char" rowspan="1" colspan="1">65.0&#x000b1;15.2</td><td align="char" rowspan="1" colspan="1">74.5&#x000b1;18.3 <xref ref-type="table-fn" rid="TFN2">**</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;3.09</td><td align="char" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="char" rowspan="1" colspan="1">160.4&#x000b1;9.4</td><td align="char" rowspan="1" colspan="1">165.5&#x000b1;8.9 <xref ref-type="table-fn" rid="TFN2">**</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;3.18</td><td align="char" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="char" rowspan="1" colspan="1">25.3&#x000b1;5.5</td><td align="char" rowspan="1" colspan="1">27.0&#x000b1;5.3</td><td align="char" rowspan="1" colspan="1">&#x02212;1.88</td><td align="char" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI <italic>z</italic> -score</td><td align="char" rowspan="1" colspan="1">1.6&#x000b1;1.3</td><td align="char" rowspan="1" colspan="1">1.9&#x000b1;1.2</td><td align="char" rowspan="1" colspan="1">&#x02212;1.30</td><td align="char" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">WC (cm)</td><td align="char" rowspan="1" colspan="1">84.6&#x000b1;13.6</td><td align="char" rowspan="1" colspan="1">84.9&#x000b1;13.9</td><td align="char" rowspan="1" colspan="1">1.57</td><td align="char" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">VEF<sub>1</sub> (L)</td><td align="char" rowspan="1" colspan="1">2.9&#x000b1;0.5</td><td align="char" rowspan="1" colspan="1">3.4&#x000b1;0.6 <xref ref-type="table-fn" rid="TFN2">**</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;4.28</td><td align="char" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV<sub>1</sub> (% predicted)</td><td align="char" rowspan="1" colspan="1">95.4&#x000b1;10.8</td><td align="char" rowspan="1" colspan="1">102.0&#x000b1;18.8 <xref ref-type="table-fn" rid="TFN1">*</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;2.21</td><td align="char" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">FVC (L)</td><td align="char" rowspan="1" colspan="1">3.4&#x000b1;0.7</td><td align="char" rowspan="1" colspan="1">3.9&#x000b1;0.8 <xref ref-type="table-fn" rid="TFN2">**</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;3.57</td><td align="char" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" rowspan="1" colspan="1">FVC (% predicted)</td><td align="char" rowspan="1" colspan="1">102.3&#x000b1;12.2</td><td align="char" rowspan="1" colspan="1">106.0&#x000b1;13.4</td><td align="char" rowspan="1" colspan="1">&#x02212;1.61</td><td align="char" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV<sub>1</sub>/FVC (%) <xref ref-type="table-fn" rid="TFN3">a</xref>
</td><td align="char" rowspan="1" colspan="1">86.7&#x000b1;10.3</td><td align="char" rowspan="1" colspan="1">88.5&#x000b1;7.0 <xref ref-type="table-fn" rid="TFN1">*</xref>
</td><td align="char" rowspan="1" colspan="1">2.01</td><td align="char" rowspan="1" colspan="1">0.04</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>
<italic>p</italic> &#x0003c;0.05.</p></fn><fn id="TFN2"><label>**</label><p>
<italic>p</italic> &#x0003c;0.01.</p></fn><fn id="TFN3"><label>a</label><p>Variables without normal distribution.</p></fn><fn id="TFN4"><p>BMI, body mass index; WC, waist circumference; FEV<sub>1</sub>, forced
expiratory volume in one second; FVC, forced vital capacity;
FEV<sub>1</sub>/FVC, FEV<sub>1</sub>/FVC ratio.Values expressed in
mean&#x000b1;standard deviation.</p></fn></table-wrap-foot></table-wrap><p>Regarding the polymorphisms of the <italic>ADRB2</italic> gene, no significant
differences were found for allele 27 and for genotypes of <italic>Arg16Gly</italic> and
<italic>Gln27Glu</italic> polymorphism between the EIB+ and EIB&#x02212; groups
(<italic>p</italic>=0.26; <italic>p</italic>=0.97 and <italic>p</italic>=0.43,
respectively). However, there was a trend toward statistical significance for a greater
proportion of polymorphisms at allele 16 in the EIB+ group when compared to the EIB&#x02212;
(<italic>p</italic>=0.08) (<xref ref-type="table" rid="t2">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Frequency of alleles and genotypes of <italic>ADRB2</italic> gene between the
groups present (+) and absent (&#x02212;) exercise-induced bronchospasm.</title></caption><table frame="hsides" rules="groups" style="border-color:#376bad"><colgroup span="1"><col span="1" width="1%"/><col span="1" width="19%"/><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/></colgroup><thead style="background-color:#bad2ed;border-color:#376bad"><tr><th colspan="2" rowspan="1"/><th align="left" rowspan="1" colspan="1">EIB+</th><th align="left" rowspan="1" colspan="1">EIB&#x02212;</th><th align="left" rowspan="1" colspan="1">
<italic>X</italic>
<sup>2</sup>
</th><th align="left" rowspan="1" colspan="1">
<italic>p</italic> -value</th></tr></thead><tbody style="background-color:#e5edf8;border-color:#376bad"><tr><td align="left" colspan="6" rowspan="1">
<italic>Alleles</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Arg</td><td align="char" rowspan="1" colspan="1">30 (37.5%)</td><td align="char" rowspan="1" colspan="1">103 (48.6%)</td><td align="left" rowspan="3" colspan="1">2.87</td><td align="left" rowspan="3" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Gly</td><td align="char" rowspan="1" colspan="1">50 (62.5%)</td><td align="char" rowspan="1" colspan="1">109 (51.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="char" rowspan="1" colspan="1">80 (100%)</td><td align="char" rowspan="1" colspan="1">212 (100%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Gln</td><td align="char" rowspan="1" colspan="1">47 (69.1%)</td><td align="char" rowspan="1" colspan="1">140 (69.3%)</td><td align="left" rowspan="3" colspan="1">0.001</td><td align="left" rowspan="3" colspan="1">0.97</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Glu</td><td align="char" rowspan="1" colspan="1">21 (30.9%)</td><td align="char" rowspan="1" colspan="1">62 (30.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="char" rowspan="1" colspan="1">68 (100%)</td><td align="char" rowspan="1" colspan="1">202 (100%)</td></tr><tr><td align="left" colspan="6" rowspan="1"/></tr><tr><td align="left" colspan="6" rowspan="1">
<italic>Genotypes</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ArgArg</td><td align="char" rowspan="1" colspan="1">7 (17.5%)</td><td align="char" rowspan="1" colspan="1">28 (26.4%)</td><td align="left" rowspan="4" colspan="1">2.64</td><td align="left" rowspan="4" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ArgGly</td><td align="char" rowspan="1" colspan="1">16 (40.0%)</td><td align="char" rowspan="1" colspan="1">47 (44.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GlyGly</td><td align="char" rowspan="1" colspan="1">17 (42.5%)</td><td align="char" rowspan="1" colspan="1">31 (29.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="char" rowspan="1" colspan="1">40 (100%)</td><td align="char" rowspan="1" colspan="1">106 (100%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GlnGln</td><td align="char" rowspan="1" colspan="1">19 (55.9%)</td><td align="char" rowspan="1" colspan="1">51 (50.5%)</td><td align="left" rowspan="4" colspan="1">1.68</td><td align="left" rowspan="4" colspan="1">0.43</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GlnGlu</td><td align="char" rowspan="1" colspan="1">9 (26.5%)</td><td align="char" rowspan="1" colspan="1">38 (37.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GluGlu</td><td align="char" rowspan="1" colspan="1">6 (17.6%)</td><td align="char" rowspan="1" colspan="1">12 (11.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total</td><td align="char" rowspan="1" colspan="1">34 (100%)</td><td align="char" rowspan="1" colspan="1">101 (100%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>
<italic>Arg</italic> , arginine; <italic>Gly</italic> , glycine;
<italic>Gln</italic> , glutamine; <italic>Glu</italic> , glutamic acid;
values expressed in absolute and relative frequencies.</p></fn></table-wrap-foot></table-wrap><p>The percentage of maximum FEV<sub>1</sub> decrease showed a moderate correlation with
the presence of asthma (rho=0.47; <italic>p</italic>&#x0003c;0.01). However, for the
variables BMI <italic>z</italic>-score (rho=0.01), WC (rho=0.20), polymorphisms
<italic>Arg16Gly</italic> (&#x02212;0.01) and <italic>Gln27Glu</italic> (rho=&#x02212;0.07) showed no
significant correlations.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The aim of this study was to determine the influence of polymorphisms in the
<italic>ADRB2</italic> gene on the triggering of EIB in adolescents. There were no
significant differences in frequencies for allele 27 and for the genotypes of allele
<italic>Arg16Gly</italic> and <italic>Gln27Glu</italic> in the EIB+ group compared to
the EIB&#x02212;, which partly refutes our initial hypothesis. However, there was a trend toward
statistical significance for a higher frequency of allele 16 in the EIB+ group when
compared to the EIB&#x02212;. This finding may be regarded as evidence of the association
between polymorphisms in the <italic>ADRB2</italic> gene and the presence of EIB.</p><p>Individuals diagnosed with EIB+ have reduced pulmonary function compared to EIB&#x02212;
individuals, except for FVC (% of predicted), which did not differ between the two
groups.<xref rid="B23" ref-type="bibr">23</xref>
</p><p>On the other hand, previous studies did not identify such differences when assessing
obese adolescents,<xref rid="B3" ref-type="bibr">3</xref> and obese asthmatics<xref rid="B24" ref-type="bibr">24</xref> and obese individuals with rhinitis.<xref rid="B25" ref-type="bibr">25</xref> These divergences may be explained by differences
in age and initial height of the groups in the present study.</p><p>The percentage of maximum FEV<sub>1</sub> decrease showed moderate correlation with a
history of asthma, which differs from the results found by Cichalewski et al.<xref rid="B26" ref-type="bibr">26</xref> The methodological differences in the diagnosis
of EIB can explain this discrepancy, as the present study used a bronchial provocation
test on treadmill and in the study of Cichalewski et al.,<xref rid="B26" ref-type="bibr">26</xref> it was performed 45min after a physical education class. On the other
hand, neither study identified an association between EIB and BMI.</p><p>No previous studies were found to assess the frequency of <italic>ADRB2</italic>
polymorphisms in individuals with and without EIB. In this study, the frequency of
allele <italic>Gly16</italic> was 62.5% and 30.7% for allele Glu27. The proportion of
the first was higher than the one found in a study in asthmatics, which was 46.6%.<xref rid="B8" ref-type="bibr">8</xref> However, it is similar to the findings for the
general population (61%).<xref rid="B27" ref-type="bibr">27</xref> The frequency of
allele <italic>Glu27</italic> was similar between the studies.<xref rid="B8" ref-type="bibr">8</xref>
<sup>,</sup>
<xref rid="B27" ref-type="bibr">27</xref>
</p><p>A study carried out by Snyder et al.<xref rid="B28" ref-type="bibr">28</xref> observed
in healthy adults that individuals with the <italic>Arg16Arg</italic> and
<italic>Gly16Gly</italic> genotypes had similar responses to bronchodilation during
exercise. However, after the end of the test, individuals that were homozygous for
allele <italic>Arg16</italic> returned more quickly to baseline when compared to
<italic>Gly16</italic> homozygotes. The authors explain this finding by a possible
desensitization of the <italic>ADRB2</italic> gene in this population. These results
differ from those found in this study, which showed no differences in frequency between
the genotypes and can actually confirm that there is no influence of this gene in
individuals with EIB.</p><p>The polymorphisms of <italic>ADRB2</italic> gene might be related to asthma, mainly due
to being associated with increased airway sensitivity.<xref rid="B8" ref-type="bibr">8</xref> Bronchial hyper-responsiveness is one of the main characteristics of asthma
and may be triggered by several factors, including exercise.<xref rid="B29" ref-type="bibr">29</xref> The study carried out by Fukui et al.<xref rid="B30" ref-type="bibr">30</xref> showed that individuals with increased responsiveness to
methacholine challenge test had a polymorphism at codon 16. EIB can be considered an
exaggerated airway response.<xref rid="B1" ref-type="bibr">1</xref> Thus, it was
expected that polymorphisms had an effect on the bronchoconstrictor response to
exercise, which ultimately did not occur.</p><p>The cross-sectional study design limits the causal associations between the variables.
Another issue to be emphasized as a limiting factor is the low number of participants
for the analysis of genetic polymorphisms, leading to a cautious interpretation of the
study findings. We suggest studies with larger sample sizes to confirm the association
between the presence of the <italic>Gly</italic>16 allele and the manifestation of EIB.
Further studies are required with the control of the aforementioned limitations and the
use of spirometry at times 3; 5; 10; 15 and 30min after bronchial provocation challenge
tests to prevent possible EIB misdiagnosis.</p><p>We conclude that the presence of polymorphisms associated with <italic>Glu27</italic>
allele and <italic>Arg16Gly</italic> and <italic>Gln27Glu</italic> genotypes did not
influence EIB expression. However, the statistical trend for increased frequency of
allele <italic>Gly16</italic> in individuals with EIB can be considered an indication of
the influence of polymorphisms on the gene <italic>ADBR2</italic> in EIB in
adolescents.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p>
<bold>Funding</bold>
</p><p>Funda&#x000e7;&#x000e3;o Arauc&#x000e1;ria, process n. 19.281.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiler</surname><given-names>JM</given-names></name><name><surname>Anderson</surname><given-names>SD</given-names></name><name><surname>Randolph</surname><given-names>C</given-names></name><name><surname>Bonini</surname><given-names>S</given-names></name><name><surname>Craig</surname><given-names>TJ</given-names></name><name><surname>Pearlman</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Pathogenesis, prevalence, diagnosis, and management of
exercise-induced bronchoconstriction: a practice parameter</article-title><source>Ann Allergy Asthma Immunol</source><year>2010</year><volume>105</volume><issue>Suppl. 6</issue><fpage>1</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">20642196</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johannson</surname><given-names>H</given-names></name><name><surname>Norlander</surname><given-names>K</given-names></name><name><surname>Hedenstr&#x000f6;m</surname><given-names>H</given-names></name><name><surname>Janson</surname><given-names>C</given-names></name><name><surname>Nordang</surname><given-names>L</given-names></name><name><surname>Nordvall</surname><given-names>L</given-names></name><etal/></person-group><article-title>Exercise-induced dyspnea is a problem among the general adolescent
population</article-title><source>Respir Med</source><year>2014</year><volume>108</volume><fpage>852</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">24731799</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>WA</given-names></name><name><surname>Ros&#x000e1;rio</surname><given-names>N</given-names></name><name><surname>Leite</surname><given-names>N</given-names></name></person-group><article-title>Broncoespasmo induzido pelo exerc&#x000ed;cio em adolescentes asm&#x000e1;ticos obesos
e n&#x000e3;o obesos</article-title><source>Rev Paul Pediatr</source><year>2010</year><volume>28</volume><fpage>36</fpage><lpage>40</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulain</surname><given-names>M</given-names></name><name><surname>Doucet</surname><given-names>M</given-names></name><name><surname>Major</surname><given-names>GC</given-names></name><name><surname>Drapeau</surname><given-names>V</given-names></name><name><surname>S&#x000e9;ri&#x000e8;s</surname><given-names>F</given-names></name><name><surname>Boulet</surname><given-names>LP</given-names></name><etal/></person-group><article-title>The effect of obesity on chronic respiratory diseases: pathophysiology
and therapeutic strategies</article-title><source>CMAJ</source><year>2006</year><volume>174</volume><fpage>1293</fpage><lpage>1299</lpage><pub-id pub-id-type="pmid">16636330</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>MA</given-names></name><name><surname>Leite</surname><given-names>N</given-names></name></person-group><chapter-title>Asma br&#x000f4;nquica, doen&#x000e7;a obstrutiva pulmonar e exerc&#x000ed;cio
f&#x000ed;sico</chapter-title><person-group person-group-type="editor"><name><surname>Nabil</surname><given-names>G</given-names></name><name><surname>Dioguardi</surname><given-names>GS</given-names></name></person-group><source>Cardiologia do esporte e do exerc&#x000ed;cio</source><publisher-loc>S&#x000e3;o Paulo</publisher-loc><publisher-name>Atheneu</publisher-name><year>2007</year><fpage>443</fpage><lpage>454</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welsh</surname><given-names>L</given-names></name><name><surname>Kemp</surname><given-names>JG</given-names></name><name><surname>Roberts</surname><given-names>RG</given-names></name></person-group><article-title>Effects of physical conditioning on children and adolescents with
asthma</article-title><source>Sports Med</source><year>2005</year><volume>35</volume><fpage>127</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">15707377</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>JO</given-names></name><name><surname>Wyatt</surname><given-names>HR</given-names></name><name><surname>Peters</surname><given-names>JC</given-names></name></person-group><article-title>Energy balance and obesity</article-title><source>Circulation</source><year>2012</year><volume>126</volume><fpage>126</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">22753534</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname><given-names>AC</given-names></name><name><surname>Marson</surname><given-names>FA</given-names></name><name><surname>Ribeiro</surname><given-names>JD</given-names></name><name><surname>Bertuzzo</surname><given-names>CS</given-names></name></person-group><article-title>Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic
receptor gene as risk factors</article-title><source>Allergy Asthma Clin Immunol</source><year>2014</year><volume>10</volume><fpage>8</fpage><pub-id pub-id-type="pmid">24499171</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angeli</surname><given-names>CB</given-names></name><name><surname>Kimura</surname><given-names>L</given-names></name><name><surname>Auricchio</surname><given-names>MT</given-names></name><name><surname>Vicente</surname><given-names>JP</given-names></name><name><surname>Mattevi</surname><given-names>VS</given-names></name><name><surname>Zembrzuski</surname><given-names>VM</given-names></name><etal/></person-group><article-title>Multilocus analyses of seven candidate genes suggest interacting
pathways for obesity-related traits in Brazilian populations</article-title><source>Obesity (Silver Spring)</source><year>2011</year><volume>19</volume><fpage>1244</fpage><lpage>1251</lpage><pub-id pub-id-type="pmid">21233811</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>SW</given-names></name><name><surname>Khoo</surname><given-names>SK</given-names></name><name><surname>Laing</surname><given-names>IA</given-names></name><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Gibson</surname><given-names>NA</given-names></name><name><surname>Rye</surname><given-names>P</given-names></name><etal/></person-group><article-title>Beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung
function and asthma in infants and children</article-title><source>Clin Exp Allergy</source><year>2004</year><volume>34</volume><fpage>1043</fpage><lpage>1048</lpage><pub-id pub-id-type="pmid">15248848</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>SP</given-names></name><name><surname>Mathie</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>JA</given-names></name></person-group><article-title>Guide to receptors and channels (GRAC), 5th edition</article-title><source>Br J Pharmacol</source><year>2011</year><volume>164</volume><issue>Suppl. 1</issue><fpage>S1</fpage><lpage>S324</lpage><pub-id pub-id-type="pmid">22040146</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>A</given-names></name><name><surname>Torchio</surname><given-names>R</given-names></name><name><surname>Bertolaccini</surname><given-names>L</given-names></name><name><surname>Terzi</surname><given-names>A</given-names></name><name><surname>Rolfo</surname><given-names>F</given-names></name><name><surname>Agostini</surname><given-names>P</given-names></name><etal/></person-group><article-title>Contribution of &#x003b2;2-adrenergic receptors to exercise-induced
bronchodilatation in healthy humans</article-title><source>Respir Physiol Neurobiol</source><year>2012</year><volume>184</volume><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">22842007</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuso</surname><given-names>L</given-names></name><name><surname>Di Perna</surname><given-names>A</given-names></name><name><surname>Longobardi</surname><given-names>A</given-names></name><name><surname>Trov&#x000e9;</surname><given-names>A</given-names></name><name><surname>Bisceglia</surname><given-names>M</given-names></name><name><surname>Bibi</surname><given-names>BF</given-names></name><etal/></person-group><article-title>Polymorphism of Beta2-adrenoceptor and regular use of formoterol in
asthma: preliminary results</article-title><source>ISRN Pulmonol</source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>JP</given-names></name><name><surname>Hallstrand</surname><given-names>TS</given-names></name><name><surname>Mastronarde</surname><given-names>JG</given-names></name><name><surname>Kaminsky</surname><given-names>DA</given-names></name><name><surname>Rundell</surname><given-names>KW</given-names></name><name><surname>Hull</surname><given-names>JH</given-names></name><etal/></person-group><article-title>An official American Thoracic Society clinical practice guideline:
exercise-induced bronchoconstriction</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>187</volume><fpage>1016</fpage><lpage>1027</lpage><pub-id pub-id-type="pmid">23634861</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leite</surname><given-names>N</given-names></name><name><surname>Lazarotto</surname><given-names>L</given-names></name><name><surname>Milano</surname><given-names>GE</given-names></name><name><surname>Titski</surname><given-names>AC</given-names></name><name><surname>Consentino</surname><given-names>CL</given-names></name><name><surname>Mattos</surname><given-names>F</given-names></name><etal/></person-group><article-title>ADRB2 gene association with overweight and asthma in children and
adolescents and its relationship with physical fitness</article-title><source>Rev Paul Pediatr</source><year>2015</year><volume>33</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">26409918</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="webpage"><comment>Publica&#x000e7;&#x000f5;es de Turismo</comment><comment>p&#x000e1;gina na Internet</comment><source>C&#x000e1;lculo amostral: calculadora on-line</source><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.calculoamostral.vai.la">http://www.calculoamostral.vai.la</ext-link></comment><date-in-citation content-type="access-date">03.02.15</date-in-citation></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>WHO child growth standards: length/height-for-age, weight-for-age,
weight-for-length, weight-for height and body mass index-for-age: methods and
development</source><publisher-loc>Geneva</publisher-loc><publisher-name>WHO</publisher-name><year>2006</year></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez</surname><given-names>JR</given-names></name><name><surname>Redden</surname><given-names>DT</given-names></name><name><surname>Pietrobelli</surname><given-names>A</given-names></name><name><surname>Allison</surname><given-names>DB</given-names></name></person-group><article-title>Waist circumference percentiles in nationally representative samples
of African-America, European-American, and Mexican-American children and
adolescents</article-title><source>J Pediatr</source><year>2004</year><volume>145</volume><fpage>439</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">15480363</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Sociedade Brasileira de Pneumologia e Tisiologia</collab></person-group><article-title>III Consenso Brasileiro de manejo da asma</article-title><source>J Pneumol</source><year>2002</year><volume>28</volume><fpage>S6</fpage><lpage>S51</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knudson</surname><given-names>RJ</given-names></name><name><surname>Slatin</surname><given-names>RC</given-names></name><name><surname>Lebowitz</surname><given-names>MD</given-names></name><name><surname>Burrows</surname><given-names>B</given-names></name></person-group><article-title>The maximal expiratory flow-volume curve normal standards,
variability, and effects of age</article-title><source>Am Rev Respir Dis</source><year>1976</year><volume>113</volume><fpage>587</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">1267262</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Age-predicted maximal heart rate revisited</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>37</volume><fpage>153</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">11153730</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dancey</surname><given-names>C</given-names></name><name><surname>Reidy</surname><given-names>J</given-names></name></person-group><source>Estat&#x000ed;stica sem matem&#x000e1;tica para psicologia: usando SPSS para Windows</source><publisher-loc>Porto Alegre</publisher-loc><publisher-name>Artmed</publisher-name><year>2006</year></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>B</given-names></name><name><surname>Falkenberg</surname><given-names>C</given-names></name><name><surname>Weiler</surname><given-names>N</given-names></name><name><surname>Frerichs</surname><given-names>I</given-names></name></person-group><article-title>Pulmonary function testing in children and infants</article-title><source>Physiol Meas</source><year>2014</year><volume>35</volume><fpage>59</fpage><lpage>90</lpage></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulger</surname><given-names>Z</given-names></name><name><surname>Demir</surname><given-names>E</given-names></name><name><surname>Tana&#x000e7;</surname><given-names>R</given-names></name><name><surname>G&#x000f6;k&#x0015f;en</surname><given-names>D</given-names></name><name><surname>G&#x000fc;llen</surname><given-names>F</given-names></name><name><surname>Darcan</surname><given-names>S</given-names></name><etal/></person-group><article-title>The effect of childhood obesity on respiratory function tests and
airway hyperresponsiveness</article-title><source>Turk J Pediatr</source><year>2006</year><volume>48</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">16562785</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakkhong</surname><given-names>K</given-names></name><name><surname>Kamchaisatian</surname><given-names>W</given-names></name><name><surname>Vilaiyuk</surname><given-names>S</given-names></name><name><surname>Sasisakulporn</surname><given-names>C</given-names></name><name><surname>Teawsomboonkit</surname><given-names>W</given-names></name><name><surname>Pornsuriyasak</surname><given-names>P</given-names></name><etal/></person-group><article-title>Exercise-induced bronchoconstriction in rhinitis children without
asthma</article-title><source>Asian Pac J Allergy Immunol</source><year>2011</year><volume>29</volume><fpage>278</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">22053599</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cichalewski</surname><given-names>&#x00141;</given-names></name><name><surname>Majak</surname><given-names>P</given-names></name><name><surname>Jerzy&#x00144;ska</surname><given-names>J</given-names></name><name><surname>Stelmach</surname><given-names>W</given-names></name><name><surname>Kaczmarek</surname><given-names>A</given-names></name><name><surname>Malewska</surname><given-names>K</given-names></name><etal/></person-group><article-title>Prevalence of exercise-induced cough in schoolchildren: a pilot
study</article-title><source>Allergy Asthma Proc</source><year>2015</year><volume>36</volume><fpage>65</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">25562558</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liggett</surname><given-names>SB</given-names></name></person-group><article-title>&#x003b2;2-Adrenergic receptor pharmacogenetics</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>161</volume><fpage>197</fpage><lpage>201</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snyder</surname><given-names>EM</given-names></name><name><surname>Beck</surname><given-names>KC</given-names></name><name><surname>Dietz</surname><given-names>NM</given-names></name><name><surname>Joyner</surname><given-names>MJ</given-names></name><name><surname>Turner</surname><given-names>ST</given-names></name><name><surname>Johnson</surname><given-names>BD</given-names></name></person-group><article-title>Influence of &#x003b2;2-adrenergic receptor genotype on airway function during
exercise in healthy adults</article-title><source>Chest</source><year>2006</year><volume>129</volume><fpage>762</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">16537879</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaiwannou</surname><given-names>A</given-names></name><name><surname>Zarogoulidis</surname><given-names>P</given-names></name><name><surname>Porpodis</surname><given-names>K</given-names></name><name><surname>Spyratos</surname><given-names>D</given-names></name><name><surname>Kioumis</surname><given-names>I</given-names></name><name><surname>Pitsiou</surname><given-names>G</given-names></name><etal/></person-group><article-title>Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS):
current literature review</article-title><source>J Thorac Dis</source><year>2014</year><volume>6</volume><fpage>146</fpage><lpage>151</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukui</surname><given-names>Y</given-names></name><name><surname>Hizawa</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>D</given-names></name><name><surname>Maeda</surname><given-names>Y</given-names></name><name><surname>Jinushi</surname><given-names>E</given-names></name><name><surname>Konno</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association between nonspecific airway hyperresponsiveness and
Arg16Gly &#x003b2;2-adrenergic receptor gene polymorphism in asymptomatic healthy Japanese
subjects</article-title><source>Chest</source><year>2006</year><volume>130</volume><fpage>449</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">16899844</pub-id></element-citation></ref></ref-list></back><sub-article id="SA1" article-type="translation" xml:lang="pt"><front-stub><title-group><article-title>Influ&#x000ea;ncia dos polimorfismos no receptor beta 2 adren&#x000e9;rgico na presen&#x000e7;a
de broncoespasmo induzido pelo exerc&#x000ed;cio em adolescentes<xref ref-type="author-notes" rid="fn2">&#x02730; </xref>
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Consentino</surname><given-names>C&#x000e1;ssio Leandro M&#x000fc;he</given-names></name><xref ref-type="aff" rid="aff4">a</xref><xref ref-type="corresp" rid="c2">*</xref></contrib><contrib contrib-type="author"><name><surname>Furtado-Alle</surname><given-names>Lupe</given-names></name><xref ref-type="aff" rid="aff4">a</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Larissa Rosa da</given-names></name><xref ref-type="aff" rid="aff4">a</xref></contrib><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Wendell Arthur</given-names></name><xref ref-type="aff" rid="aff5">b</xref></contrib><contrib contrib-type="author"><name><surname>Tureck</surname><given-names>Luciane Viater</given-names></name><xref ref-type="aff" rid="aff4">a</xref></contrib><contrib contrib-type="author"><name><surname>Milano</surname><given-names>Gerusa Einsfeld</given-names></name><xref ref-type="aff" rid="aff4">a</xref></contrib><contrib contrib-type="author"><name><surname>Lazarotto</surname><given-names>Leilane</given-names></name><xref ref-type="aff" rid="aff4">a</xref></contrib><contrib contrib-type="author"><name><surname>Cavaglieri</surname><given-names>Cl&#x000e1;udia Regina</given-names></name><xref ref-type="aff" rid="aff6">c</xref></contrib><contrib contrib-type="author"><name><surname>Leite</surname><given-names>Neiva</given-names></name><xref ref-type="aff" rid="aff4">a</xref></contrib></contrib-group><aff id="aff4"><label>a</label>Universidade Federal do Paran&#x000e1; (UFPR), Curitiba, PR, Brasil</aff><aff id="aff5"><label>b</label>Universidade Estadual de Maring&#x000e1; (UEM), Ivaipor&#x000e3;, PR, Brasil</aff><aff id="aff6"><label>c</label>Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brasil</aff><author-notes><corresp id="c2"><label>*</label> Autor para correspond&#x000ea;ncia. <italic>E-mail:</italic><email>cassioleandromc@hotmail.com</email> (C.L.M. Consentino).</corresp><fn fn-type="conflict"><p>
<bold>Conflitos de interesse</bold>
</p><p>Os autores declaram n&#x000e3;o haver conflitos de interesse. LFA &#x000e9; pesquisadora da
Funda&#x000e7;&#x000e3;o Arauc&#x000e1;ria, LRS &#x000e9; bolsista de doutorado da Capes, WAL &#x000e9; bolsista de
doutorado do CNPq, CRC e NL s&#x000e3;o bolsistas de produtividade do CNPq.</p></fn><fn fn-type="other" id="fn2"><label>&#x02730; </label><p>Este artigo faz parte da disserta&#x000e7;&#x000e3;o de mestrado de C&#x000e1;ssio Leandro M&#x000fc;he
Consentino.</p></fn></author-notes><abstract><title>Resumo</title><sec><title>Objetivo:</title><p>Determinar a influ&#x000ea;ncia dos polimorfismos dos receptores adren&#x000e9;rgicos beta 2
(<italic>ADRB2</italic>) no desencadeamento de broncoespasmo induzido pelo
exerc&#x000ed;cio (BIE) em adolescentes.</p></sec><sec><title>M&#x000e9;todos:</title><p>Os sujeitos foram divididos em dois grupos: BIE presente (BIE+) (n=45) e BIE
ausente (BIE&#x02212;) (n=115). O teste de broncoprovoca&#x000e7;&#x000e3;o com exerc&#x000ed;cio foi feito com
protocolo que consistiu em caminhar/correr durante no m&#x000ed;nimo oito minutos em
intensidade superior a 85% da frequ&#x000ea;ncia card&#x000ed;aca m&#x000e1;xima, considerando como BIE
presente uma queda de 10% do volume expirat&#x000f3;rio for&#x000e7;ado no primeiro segundo
(VEF<sub>1</sub>). A genotipagem do gene <italic>ADRB2</italic> foi feita pelo
m&#x000e9;todo Taqman por meio do aparelho Step One Plus. Para an&#x000e1;lise estat&#x000ed;stica
usaram-se os testes <italic>t</italic> independente, U de Mann-Whitney,
qui-quadrado e coeficiente de correla&#x000e7;&#x000e3;o de Spearman.</p></sec><sec><title>Resultados:</title><p>Idade, massa corporal, estatura, VEF<sub>1</sub>, CVF e rela&#x000e7;&#x000e3;o
VEF<sub>1</sub>/CVF foram menores no grupo BIE+ em compara&#x000e7;&#x000e3;o com o BIE&#x02212;
(<italic>p</italic>&#x0003c;0,05). N&#x000e3;o houve diferen&#x000e7;as significativas na propor&#x000e7;&#x000e3;o
do alelo na posi&#x000e7;&#x000e3;o 27 e dos gen&#x000f3;tipos <italic>Arg16Gly</italic> e
<italic>Gln27Glu</italic> entre os grupos BIE+ e BIE&#x02212; (<italic>p</italic>=0,26;
<italic>p</italic>=0,97 e <italic>p</italic>=0,43, respectivamente).
Entretanto, verificou-se uma tend&#x000ea;ncia &#x000e0; signific&#x000e2;ncia estat&#x000ed;stica na maior
propor&#x000e7;&#x000e3;o do alelo <italic>Gly16</italic> para o grupo BIE+ comparado com o BIE&#x02212;
(<italic>p</italic>=0,08).</p></sec><sec><title>Conclus&#x000f5;es:</title><p>A presen&#x000e7;a de polimorfismos associados ao alelo <italic>Glu27</italic> e os
gen&#x000f3;tipos <italic>Arg16Gly</italic> e <italic>Gln27Glu</italic> n&#x000e3;o influenciam no
BIE. Por&#x000e9;m, a tend&#x000ea;ncia estat&#x000ed;stica observada para uma maior frequ&#x000ea;ncia do alelo
<italic>Gly16</italic> nos indiv&#x000ed;duos com a presen&#x000e7;a de BIE pode ser
considerado ind&#x000ed;cio da influ&#x000ea;ncia de polimorfismos no gene <italic>ADBR2</italic>
no BIE em adolescentes.</p></sec></abstract><kwd-group><title>PALAVRAS-CHAVE</title><kwd>Adolescente</kwd><kwd>Broncoespasmo induzido pelo exerc&#x000ed;cio</kwd><kwd>Gene <italic>ADRB2</italic></kwd></kwd-group></front-stub><body><sec><title>Introdu&#x000e7;&#x000e3;o</title><p>O broncoespasmo induzido pelo exerc&#x000ed;cio (BIE) &#x000e9; definido como estreitamento
transit&#x000f3;rio das vias a&#x000e9;reas que acontece logo ap&#x000f3;s exerc&#x000ed;cios intensos em at&#x000e9; 90% dos
indiv&#x000ed;duos asm&#x000e1;ticos<xref rid="B1" ref-type="bibr">1</xref> e em quase 20% das
pessoas sem hist&#x000f3;rico de doen&#x000e7;as respirat&#x000f3;rias.<xref rid="B2" ref-type="bibr">2</xref> A presen&#x000e7;a de excesso de peso pode contribuir para aumento da gravidade
do BIE em asm&#x000e1;tico.<xref rid="B3" ref-type="bibr">3</xref> O ac&#x000fa;mulo excessivo de
tecido adiposo na regi&#x000e3;o central pode alterar a mec&#x000e2;nica pulmonar e a resposta
inflamat&#x000f3;ria das vias a&#x000e9;reas, levar ao aumento da contratilidade e da responsividade
da musculatura lisa dos br&#x000f4;nquios<xref rid="B4" ref-type="bibr">4</xref> e limitar
assim a pr&#x000e1;tica de exerc&#x000ed;cios f&#x000ed;sicos<xref rid="B5" ref-type="bibr">5</xref> como
terap&#x000ea;utica na asma<xref rid="B6" ref-type="bibr">6</xref> e na obesidade.<xref rid="B7" ref-type="bibr">7</xref>
</p><p>Algumas altera&#x000e7;&#x000f5;es gen&#x000e9;ticas, como os polimorfismos nos receptores adren&#x000e9;rgicos beta
2 (<italic>ADRB2</italic>), t&#x000ea;m sido associadas &#x000e0; presen&#x000e7;a de asma<xref rid="B8" ref-type="bibr">8</xref> e de obesidade.<xref rid="B9" ref-type="bibr">9</xref> O gene do <italic>ADRB2</italic> est&#x000e1; localizado no cromossomo 5q31 e
pode ser encontrado em diversas regi&#x000f5;es do corpo, inclusive na musculatura lisa.<xref rid="B10" ref-type="bibr">10</xref> Os <italic>ADRB2</italic> atuam mediados pela
a&#x000e7;&#x000e3;o da adrenalina e da noradrenalina e promovem o relaxamento do m&#x000fa;sculo liso, at&#x000e9;
na regi&#x000e3;o pulmonar,<xref rid="B11" ref-type="bibr">11</xref> al&#x000e9;m de desempenhar
papel importante na broncodilata&#x000e7;&#x000e3;o durante o exerc&#x000ed;cio em indiv&#x000ed;duos saud&#x000e1;veis.<xref rid="B12" ref-type="bibr">12</xref> Os polimorfismos <italic>Arg16Gly</italic> e
<italic>Gln27Glu</italic> do gene do <italic>ADRB2</italic> v&#x000ea;m sendo relacionados
a sintomas da asma,<xref rid="B7" ref-type="bibr">7</xref> incluindo a redu&#x000e7;&#x000e3;o da
fun&#x000e7;&#x000e3;o pulmonar e da resposta broncodilatadora &#x000e0; medica&#x000e7;&#x000e3;o, pois t&#x000ea;m influ&#x000ea;ncia
negativa no efeito da medica&#x000e7;&#x000e3;o broncodilatadora,<xref rid="B13" ref-type="bibr">13</xref> recurso terap&#x000ea;utico que faz parte da preven&#x000e7;&#x000e3;o do BIE
pr&#x000e9;-exerc&#x000ed;cio.<xref rid="B14" ref-type="bibr">14</xref>
</p><p>Recentemente, nosso grupo de pesquisas verificou maior presen&#x000e7;a de polimorfismo
<italic>Arg16Gly</italic> em crian&#x000e7;as e adolescentes asm&#x000e1;ticos em compara&#x000e7;&#x000e3;o com
os controles. Al&#x000e9;m disso, verificou-se tend&#x000ea;ncia a maior frequ&#x000ea;ncia do polimorfismo
<italic>Gly16</italic> em asm&#x000e1;ticos com excesso de peso.<xref rid="B15" ref-type="bibr">15</xref> Contudo, a influ&#x000ea;ncia da presen&#x000e7;a de polimorfismo no receptor
<italic>ADRB2</italic> na presen&#x000e7;a de BIE em crian&#x000e7;as e adolescentes ainda n&#x000e3;o foi
investigada. Nossa hip&#x000f3;tese &#x000e9; que a maior frequ&#x000ea;ncia de polimorfismo no receptor
<italic>ADRB2</italic> poderia estar relacionada &#x000e0; maior presen&#x000e7;a de BIE nessa
popula&#x000e7;&#x000e3;o. Portanto, o prop&#x000f3;sito do presente estudo foi determinar a influ&#x000ea;ncia dos
polimorfismos no gene <italic>ADRB2</italic> no desencadeamento de BIE em
adolescentes.</p></sec><sec><title>M&#x000e9;todo</title><p>Estudo transversal com 160 adolescentes de ambos os sexos, de etnia branca, entre
9-17 anos, selecionados por conveni&#x000ea;ncia e provenientes de escolas p&#x000fa;blicas de
Curitiba (PR). A amostra foi dividida em dois grupos, BIE presente (BIE+) (n=45) e
BIE ausente (BIE&#x02212;) (n=115). Constatou-se presen&#x000e7;a de BIE quando houve queda maior ou
igual a 10% do VEF<sub>1</sub> em rela&#x000e7;&#x000e3;o ao valor basal no teste de broncoprovoca&#x000e7;&#x000e3;o
por exerc&#x000ed;cio. Todos os participantes e respons&#x000e1;veis assinaram o termo de
consentimento livre e esclarecido, conforme projeto de pesquisa aprovado pelo Comit&#x000ea;
de &#x000c9;tica em Pesquisa em Seres Humanos do Hospital de Cl&#x000ed;nicas da Universidade Federal
do Paran&#x000e1; (protocolo n&#x000b0; 2460.067/2011-03). O c&#x000e1;lculo amostral foi feito com n&#x000ed;vel de
confian&#x000e7;a de 95% e a f&#x000f3;rmula descrita por Santos.<xref rid="B16" ref-type="bibr">16</xref> O tamanho da amostra calculado foi de 246 escolares. Entretanto, o
n&#x000fa;mero de participantes foi de 160 adolescentes, 65% da amostra prevista, em fun&#x000e7;&#x000e3;o
da complexidade dos exames e da necessidade de coleta sangu&#x000ed;nea.</p><p>Mensurou-se a massa corporal (kg) em balan&#x000e7;a digital (Toledo<sup>&#x000ae;</sup>), com
resolu&#x000e7;&#x000e3;o de 0,1kg, e a estatura (cm) em estadi&#x000f4;metro (Sanny<sup>&#x000ae;</sup>) com
resolu&#x000e7;&#x000e3;o de 0,1cm. O &#x000cd;ndice de Massa Corporal (IMC) foi calculado pela f&#x000f3;rmula IMC
(kg/m<xref rid="B2" ref-type="bibr">2</xref>)=Massa corporal (kg)/Estatura<xref rid="B2" ref-type="bibr">2</xref> (m). Essa vari&#x000e1;vel foi convertida para
IMC-escore Z, por meio do <italic>software</italic> WHO Anthroplus v.1.0.4
desenvolvido pela Organiza&#x000e7;&#x000e3;o Mundial da Sa&#x000fa;de (OMS), classificado de acordo com os
pontos de corte propostos pela OMS em 2006.<xref rid="B17" ref-type="bibr">17</xref>
</p><p>A circunfer&#x000ea;ncia abdominal (CA) foi mensurada em cent&#x000ed;metros (cm) com fita
antropom&#x000e9;trica inextens&#x000ed;vel (Cardiomed<sup>&#x000ae;</sup>), medida no ponto m&#x000e9;dio entre o
&#x000fa;ltimo arco costal e a crista il&#x000ed;aca, com o indiv&#x000ed;duo de p&#x000e9;, abdome relaxado e bra&#x000e7;os
ao longo do corpo. Para classifica&#x000e7;&#x000e3;o, usaram-se os valores propostos por Fernand&#x000e9;z
<italic>et al</italic>., em 2004.<xref rid="B18" ref-type="bibr">18</xref>
</p><p>Para o diagn&#x000f3;stico da asma, conforme o III Consenso Brasileiro do Manejo da Asma
(SBPT, 2002),<xref rid="B19" ref-type="bibr">19</xref> usaram-se a avalia&#x000e7;&#x000e3;o m&#x000e9;dica e
o question&#x000e1;rio do International Study of Asthma and Allergies in Childhood (Isaac) e
confirmou-se a doen&#x000e7;a por meio da quest&#x000e3;o de n&#x000fa;mero 6.</p><p>A fun&#x000e7;&#x000e3;o pulmonar foi avaliada por espirometria no pr&#x000e9;-exerc&#x000ed;cio e p&#x000f3;s-exerc&#x000ed;cio (5,
10 e 15 minutos). Fizeram-se tr&#x000ea;s manobras, com o avaliado em posi&#x000e7;&#x000e3;o sentada e com
clipe nasal. Foram selecionadas as curvas que apresentaram os maiores valores para as
vari&#x000e1;veis de volume expirat&#x000f3;rio for&#x000e7;ado no primeiro segundo (VEF<sub>1</sub>) e
capacidade vital for&#x000e7;ada (CVF) em litros (L). Os valores preditos e o coeficiente
expirat&#x000f3;rio for&#x000e7;ado (VEF<sub>1</sub>/CVF) foram mostrados pelo
<italic>software</italic> do espir&#x000f4;metro (marca One Flow<sup>&#x000ae;</sup>), que usa
como refer&#x000ea;ncia os valores propostos por Knudson <italic>et al</italic>.<xref rid="B20" ref-type="bibr">20</xref>
</p><p>O teste de broncoprovoca&#x000e7;&#x000e3;o com exerc&#x000ed;cio foi feito em ambiente controlado
(temperatura entre 20-25&#x000b0;C e umidade relativa de 50%), no per&#x000ed;odo da tarde, em
esteira ergom&#x000e9;trica (modelo Master Super ATL-Inbramed), com um protocolo que
consistiu em caminhar/correr durante oito minutos, em intensidade superior a 85% da
frequ&#x000ea;ncia card&#x000ed;aca m&#x000e1;xima (FC<sub>m&#x000e1;x</sub>), de acordo com o guia da American
Thoracic Society.<xref rid="B14" ref-type="bibr">14</xref> A FC<sub>m&#x000e1;x</sub> foi
calculada por meio da f&#x000f3;rmula proposta por Tanaka <italic>et al</italic>.<xref rid="B21" ref-type="bibr">21</xref> e monitorada, durante o teste, por
frequenc&#x000ed;metro (Polar<sup>&#x000ae;</sup>). Os avaliados foram orientados a n&#x000e3;o ingerir
bebidas &#x000e0; base de cafe&#x000ed;na, duas horas antes da avalia&#x000e7;&#x000e3;o, suspender o uso de
broncodilatadores de a&#x000e7;&#x000e3;o curta e longa, 48 horas e cinco dias antes das avalia&#x000e7;&#x000f5;es,
respectivamente. O exerc&#x000ed;cio n&#x000e3;o foi feito quando houve relato de crise de asma ou
infec&#x000e7;&#x000e3;o viral nas vias a&#x000e9;reas nas &#x000fa;ltimas quatro semanas antes do teste. A
intensidade da queda foi calculada pela queda m&#x000e1;xima do VEF<sub>1</sub>
(QMVEF<sub>1</sub>) por meio da equa&#x000e7;&#x000e3;o: QMVEF<sub>1</sub>=[(VEF<sub>1</sub>
pr&#x000e9;-exerc&#x000ed;cio-VEF<sub>1</sub> p&#x000f3;s-exerc&#x000ed;cio mais baixo)/VEF<sub>1</sub>
pr&#x000e9;-exerc&#x000ed;cio]&#x000d7;100.<xref rid="B14" ref-type="bibr">14</xref>
</p><p>A extra&#x000e7;&#x000e3;o do DNA ocorreu por meio de amostra sangu&#x000ed;nea, com a genotipagem dos
polimorfismos <italic>Arg16Gly</italic> e <italic>Gln27Glu</italic> do gene
<italic>ADRB2</italic> pelo m&#x000e9;todo <italic>Taqman</italic>, por meio do kit
<italic>TaqMan SNP genotyping assays</italic> da Applied Biosystems e do
<italic>software Eppendorf realplex v.1.5</italic>, com o uso do aparelho de Step
One Plus. A seguir, foi feito um gr&#x000e1;fico de dispers&#x000e3;o (XY) para a separa&#x000e7;&#x000e3;o FAM-VIC e
consequente determina&#x000e7;&#x000e3;o do gen&#x000f3;tipo de cada adolescente para cada polimorfismo.
Classificaram-se como usuais os indiv&#x000ed;duos homozig&#x000f3;ticos para o amino&#x000e1;cido arginina
no c&#x000f3;don 16 (<italic>ArgArg</italic>) e glutamina no c&#x000f3;don 27
(<italic>GlnGln</italic>) e como portadores os indiv&#x000ed;duos homozig&#x000f3;ticos, na
posi&#x000e7;&#x000e3;o 16, para o amino&#x000e1;cido glicina (<italic>GlyGly</italic>) e, na posi&#x000e7;&#x000e3;o 27,
para &#x000e1;cido glut&#x000e2;mico (<italic>GluGlu</italic>), bem como os heterozig&#x000f3;ticos.</p><p>A an&#x000e1;lise estat&#x000ed;stica foi feita no software SPSS vers&#x000e3;o 19. A normalidade foi
verificada pelo teste de Kolmogorov-Smirnov. Para compara&#x000e7;&#x000e3;o dos grupos, aplicou-se o
teste <italic>t</italic> de Student nas vari&#x000e1;veis param&#x000e9;tricas e o teste U de
Mann-Whitney nas n&#x000e3;o param&#x000e9;tricas. O teste qui-quadrado foi usado para analisar as
propor&#x000e7;&#x000f5;es entre os grupos. A correla&#x000e7;&#x000e3;o entre as vari&#x000e1;veis foi avaliada pelo
coeficiente de correla&#x000e7;&#x000e3;o de Spearman e classificadas de acordo com Dancey e
Reidy.<xref rid="B22" ref-type="bibr">22</xref> O n&#x000ed;vel de signific&#x000e2;ncia adotado
foi de <italic>p</italic>&#x0003c;0,050.</p></sec><sec><title>Resultados</title><p>As caracter&#x000ed;sticas basais dos grupos s&#x000e3;o mostradas na <xref ref-type="table" rid="t3">tabela 1</xref>. Foram encontradas diferen&#x000e7;as nas vari&#x000e1;veis idade, massa
corporal, estatura, VEF<sub>1</sub> (tanto em litros quanto no percentual do predito)
e CVF em litros e na rela&#x000e7;&#x000e3;o VEF<sub>1</sub>/CVF, menores no grupo BIE+.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Tabela 1</label><caption><title>Caracter&#x000ed;sticas antropom&#x000e9;tricas e espirom&#x000e9;tricas basais dos grupos
broncoespasmo induzido pelo exerc&#x000ed;cio (BIE) presente (+) e ausente (&#x02212;)</title></caption><table frame="hsides" rules="groups" style="border-color:#376bad"><colgroup span="1"><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/></colgroup><thead style="background-color:#bad2ed;border-color:#376bad"><tr><th align="left" rowspan="1" colspan="1">Vari&#x000e1;veis</th><th align="left" rowspan="1" colspan="1">BIE+ <break/> (n=45)</th><th align="left" rowspan="1" colspan="1">BIE&#x02212; <break/> (n=115)</th><th align="left" rowspan="1" colspan="1">
<italic>t</italic> ou U</th><th align="left" rowspan="1" colspan="1">
<italic>p</italic> &#x02010;valor</th></tr></thead><tbody style="background-color:#e5edf8;border-color:#376bad"><tr><td align="left" rowspan="1" colspan="1">Idade (anos) <xref ref-type="table-fn" rid="TFN8">a</xref>
</td><td align="char" rowspan="1" colspan="1">13,6&#x000b1;1,6</td><td align="char" rowspan="1" colspan="1">14,5&#x000b1;1,5 <xref ref-type="table-fn" rid="TFN7">**</xref>
</td><td align="char" rowspan="1" colspan="1">4,05</td><td align="char" rowspan="1" colspan="1">0,00</td></tr><tr><td align="left" rowspan="1" colspan="1">Massa corporal (kg)</td><td align="char" rowspan="1" colspan="1">65,0&#x000b1;15,2</td><td align="char" rowspan="1" colspan="1">74,5&#x000b1;18,3 <xref ref-type="table-fn" rid="TFN7">**</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;3,09</td><td align="char" rowspan="1" colspan="1">0,00</td></tr><tr><td align="left" rowspan="1" colspan="1">Estatura (cm)</td><td align="char" rowspan="1" colspan="1">160,4&#x000b1;9,4</td><td align="char" rowspan="1" colspan="1">165,5&#x000b1;8,9 <xref ref-type="table-fn" rid="TFN7">**</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;3,18</td><td align="char" rowspan="1" colspan="1">0,00</td></tr><tr><td align="left" rowspan="1" colspan="1">IMC (kg/m<sup>2</sup>)</td><td align="char" rowspan="1" colspan="1">25,3&#x000b1;5,5</td><td align="char" rowspan="1" colspan="1">27,0&#x000b1;5,3</td><td align="char" rowspan="1" colspan="1">&#x02212;1,88</td><td align="char" rowspan="1" colspan="1">0,06</td></tr><tr><td align="left" rowspan="1" colspan="1">IMC escore&#x02010;z</td><td align="char" rowspan="1" colspan="1">1,6&#x000b1;1,3</td><td align="char" rowspan="1" colspan="1">1,9&#x000b1;1,2</td><td align="char" rowspan="1" colspan="1">&#x02212;1,30</td><td align="char" rowspan="1" colspan="1">0,19</td></tr><tr><td align="left" rowspan="1" colspan="1">CA (cm)</td><td align="char" rowspan="1" colspan="1">84,6&#x000b1;13,6</td><td align="char" rowspan="1" colspan="1">84,9&#x000b1;13,9</td><td align="char" rowspan="1" colspan="1">1,57</td><td align="char" rowspan="1" colspan="1">0,12</td></tr><tr><td align="left" rowspan="1" colspan="1">VEF<sub>1</sub> (L)</td><td align="char" rowspan="1" colspan="1">2,9&#x000b1;0,5</td><td align="char" rowspan="1" colspan="1">3,4&#x000b1;0,6 <xref ref-type="table-fn" rid="TFN7">**</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;4,28</td><td align="char" rowspan="1" colspan="1">0,00</td></tr><tr><td align="left" rowspan="1" colspan="1">VEF<sub>1</sub> (% predito)</td><td align="char" rowspan="1" colspan="1">95,4&#x000b1;10,8</td><td align="char" rowspan="1" colspan="1">102,0&#x000b1;18,8 <xref ref-type="table-fn" rid="TFN6">*</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;2,21</td><td align="char" rowspan="1" colspan="1">0,02</td></tr><tr><td align="left" rowspan="1" colspan="1">CVF (L)</td><td align="char" rowspan="1" colspan="1">3,4&#x000b1;0,7</td><td align="char" rowspan="1" colspan="1">3,9&#x000b1;0,8 <xref ref-type="table-fn" rid="TFN7">**</xref>
</td><td align="char" rowspan="1" colspan="1">&#x02212;3,57</td><td align="char" rowspan="1" colspan="1">0,00</td></tr><tr><td align="left" rowspan="1" colspan="1">CVF (% predito)</td><td align="char" rowspan="1" colspan="1">102,3&#x000b1;12,2</td><td align="char" rowspan="1" colspan="1">106,0&#x000b1;13,4</td><td align="char" rowspan="1" colspan="1">&#x02212;1,61</td><td align="char" rowspan="1" colspan="1">0,10</td></tr><tr><td align="left" rowspan="1" colspan="1">VEF<sub>1</sub>/CVF (%) <xref ref-type="table-fn" rid="TFN8">a</xref>
</td><td align="char" rowspan="1" colspan="1">86,7&#x000b1;10,3</td><td align="char" rowspan="1" colspan="1">88,5&#x000b1;7,0 <xref ref-type="table-fn" rid="TFN6">*</xref>
</td><td align="char" rowspan="1" colspan="1">2,01</td><td align="char" rowspan="1" colspan="1">0,04</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><label>*</label><p>
<italic>p</italic> &#x0003c;0,05;</p></fn><fn id="TFN7"><label>**</label><p>
<italic>p</italic> &#x0003c;0,01.</p></fn><fn id="TFN8"><label>a</label><p>Vari&#x000e1;veis que n&#x000e3;o apresentaram distribui&#x000e7;&#x000e3;o normal.</p></fn><fn id="TFN09"><p>IMC, &#x000ed;ndice de massa corporal; CA, circunfer&#x000ea;ncia abdominal;
VEF<sub>1</sub>, volume expirat&#x000f3;rio for&#x000e7;ado no 1&#x000b0; segundo; CVF, capacidade
vital for&#x000e7;ada; VEF<sub>1</sub>/CVF, raz&#x000e3;o entre VEF<sub>1</sub> e
CVF.Valores expressos em m&#x000e9;dia &#x000b1; desvio padr&#x000e3;o.</p></fn></table-wrap-foot></table-wrap><p>Com rela&#x000e7;&#x000e3;o aos polimorfismos do gene do <italic>ADRB2</italic>, n&#x000e3;o foram
encontradas diferen&#x000e7;as significativas para o alelo 27 e para os gen&#x000f3;tipos do
polimorfismo <italic>Arg16Gly</italic> e <italic>Gln27Glu</italic> entre os grupos
BIE+ e BIE&#x02212; (<italic>p</italic>=0,26; <italic>p</italic>=0,97 e
<italic>p</italic>=0,43, respectivamente). Por&#x000e9;m, foi encontrada uma tend&#x000ea;ncia &#x000e0;
signific&#x000e2;ncia estat&#x000ed;stica para maior propor&#x000e7;&#x000e3;o de polimorfismo do alelo 16 entre o
grupo BIE+ comparado com o BIE&#x02212; (<italic>p</italic>=0,08) (<xref ref-type="table" rid="t4">tabela 2</xref>).</p><table-wrap id="t4" orientation="portrait" position="float"><label>Tabela 2</label><caption><title>Frequ&#x000ea;ncia dos alelos e gen&#x000f3;tipos do gene <italic>ADRB2</italic> entre os
grupos broncoespasmo induzido pelo exerc&#x000ed;cio (BIE) presente (+) e ausente
(&#x02212;)</title></caption><table frame="hsides" rules="groups" style="border-color:#376bad"><colgroup span="1"><col span="1" width="1%"/><col span="1" width="19%"/><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/><col span="1" width="20%"/></colgroup><thead style="background-color:#bad2ed;border-color:#376bad"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">BIE+</th><th align="left" rowspan="1" colspan="1">BIE&#x02212;</th><th align="left" rowspan="1" colspan="1">
<italic>X</italic>
<sup><italic>2</italic></sup>
</th><th align="left" rowspan="1" colspan="1">
<italic>p</italic> &#x02010;valor</th></tr></thead><tbody style="background-color:#e5edf8;border-color:#376bad"><tr><td align="left" colspan="6" rowspan="1">
<italic>Alelos</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> Arg</td><td align="char" rowspan="1" colspan="1">30 (37,5%)</td><td align="char" rowspan="1" colspan="1">103 (48,6%)</td><td align="left" rowspan="3" colspan="1">2,87</td><td align="left" rowspan="3" colspan="1">0,08</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> Gly</td><td align="char" rowspan="1" colspan="1">50 (62,5%)</td><td align="char" rowspan="1" colspan="1">109 (51,4%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<italic>Total</italic>
</td><td align="char" rowspan="1" colspan="1">80 (100%)</td><td align="char" rowspan="1" colspan="1">212 (100%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> Gln</td><td align="char" rowspan="1" colspan="1">47 (69,1%)</td><td align="char" rowspan="1" colspan="1">140 (69,3%)</td><td align="left" rowspan="3" colspan="1">0,001</td><td align="left" rowspan="3" colspan="1">0,97</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> Glu</td><td align="char" rowspan="1" colspan="1">21 (30,9%)</td><td align="char" rowspan="1" colspan="1">62 (30,7%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> Total</td><td align="char" rowspan="1" colspan="1">68 (100%)</td><td align="char" rowspan="1" colspan="1">202 (100%)</td></tr><tr><td align="left" colspan="6" rowspan="1"/></tr><tr><td align="left" colspan="6" rowspan="1">Gen&#x000f3;tipos</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> ArgArg</td><td align="char" rowspan="1" colspan="1">7 (17,5%)</td><td align="char" rowspan="1" colspan="1">28 (26,4%)</td><td align="left" rowspan="4" colspan="1">2,64</td><td align="left" rowspan="4" colspan="1">0,26</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> ArgGly</td><td align="char" rowspan="1" colspan="1">16 (40,0%)</td><td align="char" rowspan="1" colspan="1">47 (44,4%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> GlyGly</td><td align="char" rowspan="1" colspan="1">17 (42,5%)</td><td align="char" rowspan="1" colspan="1">31 (29,2%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<italic>Total</italic>
</td><td align="char" rowspan="1" colspan="1">40 (100%)</td><td align="char" rowspan="1" colspan="1">106 (100%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> GlnGln</td><td align="char" rowspan="1" colspan="1">19 (55,9%)</td><td align="char" rowspan="1" colspan="1">51 (50,5%)</td><td align="left" rowspan="4" colspan="1">1,68</td><td align="left" rowspan="4" colspan="1">0,43</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> GlnGlu</td><td align="char" rowspan="1" colspan="1">9 (26,5%)</td><td align="char" rowspan="1" colspan="1">38 (37,6%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> GluGlu</td><td align="char" rowspan="1" colspan="1">6 (17,6%)</td><td align="char" rowspan="1" colspan="1">12 (11,9%)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"> Total</td><td align="char" rowspan="1" colspan="1">34 (100%)</td><td align="char" rowspan="1" colspan="1">101 (100%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN10"><p>
<italic>Arg</italic> , arginina; <italic>Gly</italic> , glicina;
<italic>Gln</italic> , glutamina; <italic>Glu</italic> , &#x000e1;cido glut&#x000e2;mico;
valores expressos em frequ&#x000ea;ncia absoluta e relativa.</p></fn></table-wrap-foot></table-wrap><p>O percentual de queda m&#x000e1;xima do VEF<sub>1</sub> apresentou correla&#x000e7;&#x000e3;o moderada com a
presen&#x000e7;a de asma (rho=0,47; <italic>p</italic>&#x0003c;0,01). Entretanto, para as
vari&#x000e1;veis IMC escore-z (rho=0,01), CA (rho=0,20), polimorfismo
<italic>Arg16Gly</italic> (&#x02212;0,01) e <italic>Gln27Glu</italic> (rho=&#x02212;0,07) n&#x000e3;o
foram encontradas correla&#x000e7;&#x000f5;es significativas.</p></sec><sec><title>Discuss&#x000e3;o</title><p>O objetivo do presente estudo foi determinar a influ&#x000ea;ncia dos polimorfismos no gene
<italic>ADRB2</italic> no desencadeamento de BIE em adolescentes. N&#x000e3;o foram
encontradas diferen&#x000e7;as significativas nas frequ&#x000ea;ncias para o alelo 27 e para os
gen&#x000f3;tipos do alelo <italic>Arg16Gly</italic> e <italic>Gln27Glu</italic> no grupo
BIE+ comparado com o BIE&#x02212;, o que refuta, em parte, nossa hip&#x000f3;tese inicial. Por&#x000e9;m,
verificou-se uma tend&#x000ea;ncia &#x000e0; signific&#x000e2;ncia estat&#x000ed;stica para uma maior frequ&#x000ea;ncia do
alelo 16 no grupo BIE+ comparado com o BIE&#x02212;. Esse achado pode ser considerado um
ind&#x000ed;cio da rela&#x000e7;&#x000e3;o entre polimorfismos no gene <italic>ADRB2</italic> e a presen&#x000e7;a de
BIE.</p><p>Os indiv&#x000ed;duos com diagn&#x000f3;stico de BIE+ apresentaram fun&#x000e7;&#x000e3;o pulmonar reduzida em
rela&#x000e7;&#x000e3;o aos BIE&#x02212;, com exce&#x000e7;&#x000e3;o da CVF (% do predito), que n&#x000e3;o diferiu entre os dois
grupos.<xref rid="B23" ref-type="bibr">23</xref> Por outro lado, estudos
anteriores n&#x000e3;o identificaram tais diferen&#x000e7;as ao avaliar adolescentes obesos,<xref rid="B24" ref-type="bibr">24</xref> obesos asm&#x000e1;ticos<xref rid="B3" ref-type="bibr">3</xref> e com rinite.<xref rid="B25" ref-type="bibr">25</xref> Essas
diverg&#x000ea;ncias podem ser justificadas pelas diferen&#x000e7;as na idade e na estatura inicial
dos grupos na presente pesquisa.</p><p>O percentual de queda m&#x000e1;xima VEF1 apresentou correla&#x000e7;&#x000e3;o moderada com hist&#x000f3;rico de
asma, o que difere do resultado encontrado por Cichalewski <italic>et
al</italic>.<xref rid="B26" ref-type="bibr">26</xref> As diferen&#x000e7;as metodol&#x000f3;gicas
quanto ao diagn&#x000f3;stico do BIE podem explicar essa discrep&#x000e2;ncia, visto que na presente
pesquisa foi feito teste de broncoprovoca&#x000e7;&#x000e3;o em esteira e, no estudo de Cichalewski
<italic>et al</italic>.,<xref rid="B26" ref-type="bibr">26</xref> foi feito 45
minutos ap&#x000f3;s uma aula de educa&#x000e7;&#x000e3;o f&#x000ed;sica. Por outro lado, ambas as pesquisas n&#x000e3;o
identificaram rela&#x000e7;&#x000e3;o do BIE com IMC.</p><p>N&#x000e3;o foram encontrados estudos anteriores que avaliassem a frequ&#x000ea;ncia dos
polimorfismos <italic>ADRB2</italic> em indiv&#x000ed;duos com e sem BIE. Nesta pesquisa, a
frequ&#x000ea;ncia do alelo <italic>Gly16</italic> foi de 62,5% e 30,7% para o alelo
<italic>Glu27</italic>. A propor&#x000e7;&#x000e3;o do primeiro foi mais elevada do que em estudo
feito em asm&#x000e1;ticos que encontrou 46,6%.<xref rid="B8" ref-type="bibr">8</xref>
Entretanto, &#x000e9; semelhante aos achados para a popula&#x000e7;&#x000e3;o em geral (61%).<xref rid="B27" ref-type="bibr">27</xref> A frequ&#x000ea;ncia do alelo <italic>Glu27</italic>
foi semelhante entre os estudos.<xref rid="B8" ref-type="bibr">8</xref>
<sup>,</sup>
<xref rid="B27" ref-type="bibr">27</xref>
</p><p>Estudo feito por Snyder <italic>et al</italic>.<xref rid="B28" ref-type="bibr">28</xref> observou, em adultos saud&#x000e1;veis, que aqueles com o gen&#x000f3;tipo
<italic>Arg16Arg</italic> e <italic>Gly16Gly</italic> t&#x000ea;m respostas similares &#x000e0;
broncodilata&#x000e7;&#x000e3;o durante o exerc&#x000ed;cio. Entretanto, ap&#x000f3;s o t&#x000e9;rmino da prova, os
indiv&#x000ed;duos homozigotos para o alelo <italic>Arg16</italic> retornam de forma mais
r&#x000e1;pida aos valores basais ao ser comparados com os homozig&#x000f3;ticos
<italic>Gly16</italic>. Os autores justificam tal achado por uma poss&#x000ed;vel
dessensibiliza&#x000e7;&#x000e3;o do gene <italic>ADRB2</italic> nessa popula&#x000e7;&#x000e3;o. Esses resultados
diferem dos encontrados neste estudo, no qual n&#x000e3;o se notaram diferen&#x000e7;as na frequ&#x000ea;ncia
entre os gen&#x000f3;tipos, o que pode realmente confirmar n&#x000e3;o haver influ&#x000ea;ncia desse gene
nos indiv&#x000ed;duos com BIE.</p><p>Os polimorfismos do gene <italic>ADRB2</italic> podem estar relacionados com a asma
principalmente por estar associados a maior sensibilidade nas vias a&#x000e9;reas.<xref rid="B8" ref-type="bibr">8</xref> A hiper-responsividade br&#x000f4;nquica &#x000e9; uma das
caracter&#x000ed;sticas primordiais da asma e pode ser desencadeada por diversos fatores,
dentre eles o exerc&#x000ed;cio.<xref rid="B29" ref-type="bibr">29</xref> Estudo feito por
Fukui <italic>et al</italic>.<xref rid="B30" ref-type="bibr">30</xref> mostrou que os
indiv&#x000ed;duos com maior responsividade ao teste provocado por metacolina apresentavam
polimorfismo no c&#x000f3;don 16. O BIE pode ser considerado como uma resposta exacerbada das
vias a&#x000e9;reas.<xref rid="B1" ref-type="bibr">1</xref> Assim, esperava-se que os
polimorfismos apresentassem influ&#x000ea;ncia na resposta broncoconstritora ao exerc&#x000ed;cio, o
que acabou n&#x000e3;o ocorrendo.</p><p>O desenho transversal do estudo limita as rela&#x000e7;&#x000f5;es de casualidade entre as vari&#x000e1;veis.
Outra quest&#x000e3;o a destacar como fator limitante &#x000e9; o baixo n&#x000fa;mero de participantes para
as an&#x000e1;lises de polimorfismos gen&#x000e9;ticos, o que leva &#x000e0; interpreta&#x000e7;&#x000e3;o cautelosa dos
achados da pesquisa. Sugerem-se estudos com maior n&#x000fa;mero de indiv&#x000ed;duos para confirmar
a associa&#x000e7;&#x000e3;o entre a presen&#x000e7;a do alelo <italic>Gly</italic>16 e a manifesta&#x000e7;&#x000e3;o de
BIE. H&#x000e1; necessidade de novas investiga&#x000e7;&#x000f5;es com o controle das limita&#x000e7;&#x000f5;es citadas e
com o uso da espirometria nos tempos 3; 5; 10 15 e 30 minutos ap&#x000f3;s teste de
broncoprovoca&#x000e7;&#x000e3;o por exerc&#x000ed;cio, para evitar poss&#x000ed;veis erros de diagn&#x000f3;stico do
BIE.</p><p>Conclui-se que a presen&#x000e7;a de polimorfismos associados ao alelo <italic>Glu27</italic>
e aos gen&#x000f3;tipos <italic>Arg16Gly</italic> e <italic>Gln27Glu</italic> n&#x000e3;o influenciou
na manifesta&#x000e7;&#x000e3;o de BIE. Por&#x000e9;m, a tend&#x000ea;ncia estat&#x000ed;stica observada para uma maior
frequ&#x000ea;ncia do alelo <italic>Gly16</italic> nos indiv&#x000ed;duos com a presen&#x000e7;a de BIE pode
ser considerada um ind&#x000ed;cio da influ&#x000ea;ncia de polimorfismos no gene
<italic>ADBR2</italic> no BIE em adolescentes.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p>
<bold>Financiamento</bold>
</p><p>Funda&#x000e7;&#x000e3;o Arauc&#x000e1;ria, processo n&#x000ba; 19.281.</p></fn></fn-group></back></sub-article></article>